Genprex, Inc. Research And Development Expense

• Genprex, Inc. showed a decrease of -10.5% in Research And Development Expense from 2024 to 2025.
• This data is from Genprex, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
• XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 10 years of available data (2016 to 2025), Genprex, Inc.'s Research And Development Expense has grown by 2,556.9%.
• Historical annual values: Fiscal year 2025: $9.43 million | Fiscal year 2024: $10.54 million | Fiscal year 2023: $17.62 million | Fiscal year 2022: $11.51 million | Fiscal year 2021: $8.97 million | Fiscal year 2020: $7.30 million | Fiscal year 2019: $1.97 million | Fiscal year 2018: $971.4 thousand | Fiscal year 2017: $289.9 thousand | Fiscal year 2016: $354.9 thousand.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026